These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 8769300)

  • 1. Interferon-alpha therapy may induce insulin autoantibody development in patients with chronic viral hepatitis.
    di Cesare E; Previti M; Russo F; Brancatelli S; Ingemi MC; Scoglio R; Mazzù N; Cucinotta D; Raimondo G
    Dig Dis Sci; 1996 Aug; 41(8):1672-7. PubMed ID: 8769300
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autoimmune endocrine disease induced by recombinant interferon-alpha therapy for chronic active type C hepatitis.
    Imagawa A; Itoh N; Hanafusa T; Oda Y; Waguri M; Miyagawa J; Kono N; Kuwajima M; Matsuzawa Y
    J Clin Endocrinol Metab; 1995 Mar; 80(3):922-6. PubMed ID: 7883851
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies during alpha-interferon therapy for chronic hepatitis B.
    Fattovich G; Betterle C; Brollo L; Pedini B; Giustina G; Realdi G; Alberti A; Ruol A
    J Med Virol; 1991 Jun; 34(2):132-5. PubMed ID: 1890413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients.
    Floreani A; Chiaramonte M; Greggio NA; Fabris P; De Lazzari F; Naccarato R; Betterle C
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):71-6. PubMed ID: 9615270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autoimmunity against pancreatic islets and other tissues before and after interferon-alpha therapy in patients with hepatitis C virus chronic infection.
    Betterle C; Fabris P; Zanchetta R; Pedini B; Tositti G; Bosi E; de Lalla F
    Diabetes Care; 2000 Aug; 23(8):1177-81. PubMed ID: 10937518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of chronic type B hepatitis with recombinant alpha-interferon induces autoantibodies not specific for autoimmune chronic hepatitis.
    Mayet WJ; Hess G; Gerken G; Rossol S; Voth R; Manns M; Meyer zum Büschenfelde KH
    Hepatology; 1989 Jul; 10(1):24-8. PubMed ID: 2737600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies before, during and after administration of recombinant interferon-alpha for chronic viral hepatitis.
    Lopes EP; Silva AE; Sette Junior H; Guimarães RX; Ferraz ML
    Rev Inst Med Trop Sao Paulo; 1995; 37(5):455-60. PubMed ID: 8729757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of thyroid autoimmunity after administration of recombinant human interferon-alpha 2b for chronic viral hepatitis.
    Chung YH; Shong YK
    Am J Gastroenterol; 1993 Feb; 88(2):244-7. PubMed ID: 8424429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of insulin-dependent diabetes mellitus in a patient with chronic hepatitis C during therapy with interferon-alpha.
    Eibl N; Gschwantler M; Ferenci P; Eibl MM; Weiss W; Schernthaner G
    Eur J Gastroenterol Hepatol; 2001 Mar; 13(3):295-8. PubMed ID: 11293453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serological markers of autoimmunity in renal transplant patients before and after alpha-interferon therapy for chronic hepatitis C.
    Rostaing L; Oksman F; Izopet J; Baron E; Cisterne JM; Hoff M; Abbal M; Durand D
    Am J Nephrol; 1996; 16(6):478-83. PubMed ID: 8955758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trajectories of anti-islet autoantibodies before development of type 1 diabetes in interferon-treated hepatitis C patients. Case reports and a literature review.
    Nakamura K; Kawasaki E; Abiru N; Jo O; Fukushima K; Satoh T; Kuriya G; Kobayashi M; Kuwahara H; Yamasaki H; Ide T; Eguchi K
    Endocr J; 2010; 57(11):947-51. PubMed ID: 20805634
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exacerbation of thyroid autoimmunity by interferon alpha treatment in patients with chronic viral hepatitis: our studies and review of the literature.
    Nagayama Y; Ohta K; Tsuruta M; Takeshita A; Kimura H; Hamasaki K; Ashizawa K; Nakata K; Yokoyama N; Nagataki S
    Endocr J; 1994 Oct; 41(5):565-72. PubMed ID: 7889118
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of autoantibodies to the adrenal cortex and pancreatic islet cells by interferon alpha therapy for chronic hepatitis C.
    Wesche B; Jaeckel E; Trautwein C; Wedemeyer H; Falorni A; Frank H; von zur Mühlen A; Manns MP; Brabant G
    Gut; 2001 Mar; 48(3):378-83. PubMed ID: 11171829
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Islet cell and thyroid antibody prevalence in patients with hepatitis C virus infection: effect of treatment with interferon.
    Piquer S; Hernández C; Enriquez J; Ross A; Esteban JI; Genescà J; Bonifacio E; Puig-Domingo M; Simó R
    J Lab Clin Med; 2001 Jan; 137(1):38-42. PubMed ID: 11150022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibody prevalence in chronic hepatitis B virus infection: effect in interferon alfa.
    Gregorio GV; Jones H; Choudhuri K; Vegnente A; Bortolotti F; Mieli-Vergani G; Vergani D
    Hepatology; 1996 Sep; 24(3):520-3. PubMed ID: 8781317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies and response to alpha-interferon in patients with chronic viral hepatitis.
    Saracco G; Touscoz A; Durazzo M; Rosina F; Donegani E; Chiandussi L; Gallo V; Petrino R; De Micheli AG; Solinas A
    J Hepatol; 1990 Nov; 11(3):339-43. PubMed ID: 2127054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antiplatelet antibodies in patients with chronic viral hepatitis receiving interferon-alpha.
    Christodoulou D; Christou L; Zervou E; Katsanos K; Kitsanou M; Tsianos EV
    Hepatogastroenterology; 2007 Sep; 54(78):1761-5. PubMed ID: 18019713
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of r-interferon alpha administration on hypothalamus-pituitary-thyroid axis in chronic hepatitis.
    Falaschi P; D'Urso R; Proietti A; Martocchia A; Pastore R; Angelucci L
    Life Sci; 1997; 60(1):43-50. PubMed ID: 8995531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of chronic viral hepatitis.
    Marcellin P; Benhamou JP
    Baillieres Clin Gastroenterol; 1994 Jun; 8(2):233-53. PubMed ID: 7949457
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.